Brief: HBM Holdings Says Granted Clearance Of Investigational New Drug From FDA In US
24/01/2024 04:34
Jan 24 (Reuters) - Hbm Holdings Ltd 2142.HK :
* GRANTED CLEARANCE OF INVESTIGATIONAL NEW DRUG FROM FOOD &
DRUG
ADMINISTRATION OF US
* GRANTED FDA IND CLEARANCE FOR HBM9027 CLINICAL TRIAL
INITIATION
IN US
Further company coverage: 2142.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study